Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (230) Apply Human filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Referrals Remove Referrals filter

Referral name

Referral status

European Commission final decision Remove European Commission final decision filter CMDh final position (15) Apply CMDh final position filter Opinion provided by Committee for Medicinal Products for Human Use (2) Apply Opinion provided by Committee for Medicinal Products for Human Use filter

Referral safety status

Yes (63) Apply Yes filter

Referral type

Article 29(4) referrals Remove Article 29(4) referrals filter Article 31 referrals Remove Article 31 referrals filter Article 13 referrals Remove Article 13 referrals filter Article 30 referrals (94) Apply Article 30 referrals filter Article 35 (45) Apply Article 35 filter Article 33 (43) Apply Article 33 filter Article 20 procedures (24) Apply Article 20 procedures filter Article 6(12) referrals (prior to January 2010) (21) Apply Article 6(12) referrals (prior to January 2010) filter Article 34 (20) Apply Article 34 filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 13 (6) Apply Article 13 filter Article 6(13) referrals (prior to January 2010) (5) Apply Article 6(13) referrals (prior to January 2010) filter Article 78 (5) Apply Article 78 filter Article 107i procedures (5) Apply Article 107i procedures filter Articles 39 and 40 (4) Apply Articles 39 and 40 filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (12) Apply PRAC-CHMP-EC filter PRAC-CMDh (12) Apply PRAC-CMDh filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (12) Apply Centrally and nationally authorised products (mixed) filter Nationally authorised product(s) (34) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Revocation (1) Apply Revocation filter Risk minimisation measures (12) Apply Risk minimisation measures filter Suspension (2) Apply Suspension filter Variation (7) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Date of opinion

From:

To:

Decision date

From:

To:

Medicine type

Additional monitoring (4) Apply Additional monitoring filter Exceptional circumstances (1) Apply Exceptional circumstances filter Generic (3) Apply Generic filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

230 results

Remove all filtersRemove all filters

Keyword Remove keyword

Referral type Article 31 referrals Remove Article 31 referrals filter Article 29(4) referrals Remove Article 29(4) referrals filter Article 13 referrals Remove Article 13 referrals filter

Medicine Referrals Remove Referrals filter

Referral status European Commission final decision Remove European Commission final decision filter

Sort by

List item

Referral: Valebo and associated names

alendronic acid, alfacalcidol, associated names: Tevabone, Teboneva, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 10/03/2014, Last updated: 31/03/2014
List item

Referral: Domperidone-containing medicines

domperidone, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/04/2014, EC decision date: 01/09/2014, Last updated: 11/09/2014
List item

Referral: Modified-released oral opioids

hydromorphone, morphine, oxycodone, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/11/2010, EC decision date: 20/04/2011, Last updated: 06/06/2011
List item

Referral: Inhaled corticosteroids containing medicinal products indicated in the treatment of chronic obstructive pulmonary disease

beclometasone, budesonide, flunisolide, fluticasone propionate, fluticasone furoate, Article 31 referrals
Status: European Commission final decision, opinion/position date: 28/04/2016, EC decision date: 29/06/2016, Last updated: 15/07/2016
List item

Referral: Bromocriptine-containing medicines indicated in the prevention or suppression of physiological lactation post-partum

bromocriptine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 20/08/2014, EC decision date: 30/10/2014, Last updated: 08/12/2014
List item

Referral: Merisone and associated names

tolperisone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 23/04/2015, EC decision date: 25/06/2015, Last updated: 28/07/2015
List item

Referral: Zagam

sparfloxacin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 19/12/1995, Last updated: 06/05/1996
List item

Referral: Avalox

moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, Last updated: 19/11/2013
List item

Referral: Flutiform

fluticasone propionate, formoterol fumarate, associated names: Iffeza, Flofera, Flutiformo, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 28/06/2012, Last updated: 25/10/2012
List item

Referral: Zolpidem-containing medicines

zolpidem, Article 31 referrals
Status: European Commission final decision, opinion/position date: 24/04/2014, EC decision date: 23/06/2014, Last updated: 04/08/2014
List item

Referral: Activelle

estradiol, norethisterone acetate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 26/06/2008, EC decision date: 11/09/2008, Last updated: 25/09/2008
List item

Referral: Orlistat

orlistat, Article 31 referrals
Status: European Commission final decision, opinion/position date: 16/02/2012, EC decision date: 24/04/2012, Last updated: 21/12/2012
List item

Referral: Diclofenac-containing medicines

diclofenac, Article 31 referrals
Status: European Commission final decision, opinion/position date: 26/06/2013, EC decision date: 25/09/2013, Last updated: 27/11/2013
List item

Referral: Doxagamma 4mg

Doxazosin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/06/2006, EC decision date: 11/10/2006, Last updated: 11/10/2006
List item

Referral: Combined hormonal contraceptives

desogestrel, gestodene, norgestimate, etonogestrel, drospirenone, dienogest, chlormadinone, nomegestrol, norelgestromin, Article 31 referrals
Status: European Commission final decision, opinion/position date: 16/01/2014, Last updated: 31/01/2014
List item

Referral: Lansoprazole

Lansoprazole, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/06/2007, EC decision date: 18/09/2007, Last updated: 14/12/2007
List item

Referral: Oxynal Targin and associated names

oxycodone hydrochloride, naloxone hydrochloride, Article 13 referrals
Status: European Commission final decision, opinion/position date: 23/10/2014, EC decision date: 22/12/2014, Last updated: 27/01/2015
List item

Referral: Hydroxyethyl starch solutions for infusion

hydroxyethyl starch, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/10/2013, EC decision date: 19/12/2013, Last updated: 12/01/2018
List item

Referral: Dexamed and associated names

dexamfetamine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 22/05/2014, EC decision date: 06/08/2014, Last updated: 02/09/2014
List item

Referral: Ambroxol and bromhexine-containing medicines

ambroxol, bromhexine, Article 31 referrals
Status: European Commission final decision, opinion/position date: 18/11/2015, EC decision date: 14/01/2016, Last updated: 05/02/2016
List item

Referral: Dexrazoxane

dexrazoxane, associated names: Cardioxane, Cyrdanax, Dexrazoxane Cyathus, Enaxozar, Procard, Article 31 referrals
Status: European Commission final decision, opinion/position date: 23/06/2011, EC decision date: 13/09/2011, Last updated: 16/01/2012
List item

Referral: Doxazosin "Winthrop" 4mg

Doxazosin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 28/06/2006, EC decision date: 11/10/2006, Last updated: 11/10/2006
List item

Referral: Budesonide Sandoz

budesonide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 20/02/2009, EC decision date: 07/05/2009, Last updated: 25/06/2009
List item

Referral: Loratadine Sandoz 10

loratadine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 29/05/2009, EC decision date: 06/08/2009, Last updated: 12/12/2009
List item

Referral: Bacterial lysates-containing medicinal products indicated for respiratory conditions

Article 31 referrals
Status: European Commission final decision, opinion/position date: 27/06/2019, EC decision date: 09/09/2019, Last updated: 16/09/2019

Load more

230 results

Referral: Valebo and associated names

Referral: Domperidone-containing medicines

Referral: Modified-released oral opioids

Referral: Inhaled corticosteroids containing medicinal products indicated in the treatment of chronic obstructive pulmonary disease

Referral: Bromocriptine-containing medicines indicated in the prevention or suppression of physiological lactation post-partum

Referral: Merisone and associated names

Referral: Zagam

Referral: Avalox

Referral: Flutiform

Referral: Zolpidem-containing medicines

Referral: Activelle

Referral: Orlistat

Referral: Diclofenac-containing medicines

Referral: Doxagamma 4mg

Referral: Combined hormonal contraceptives

Referral: Lansoprazole

Referral: Oxynal Targin and associated names

Referral: Hydroxyethyl starch solutions for infusion

Referral: Dexamed and associated names

Referral: Ambroxol and bromhexine-containing medicines

Referral: Dexrazoxane

Referral: Doxazosin "Winthrop" 4mg

Referral: Budesonide Sandoz

Referral: Loratadine Sandoz 10

Referral: Bacterial lysates-containing medicinal products indicated for respiratory conditions